02:24 AM EDT, 10/28/2026 (MT Newswires) -- Sandoz Group (SDZ.SW) logged a 5% year-over-year growth in constant-currency net sales for the third quarter, a Wednesday filing showed. For the three months ended Sept. 30, net sales were $2.94 billion versus $2.83 billion previously, the Switzerland-listed drugmaker said. For 2026, the group revised its constant-currency net sales growth outlook to between 5% and 6%, from the previous guidance of mid-to-high single-digit growth.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.